Free Shipping in the U.S. for orders over $1000.  Shop Now>>

CCL23 / Myeloid Progenitor Inhibitory Factor 1 Antibody [CCL23/4036]

In Stock
Catalog Number Formulation Size Price
6368-MSM6-P0
Purified Ab with BSA and Azide at 200ug/ml
20ug
$229.00
6368-MSM6-P1
Purified Ab with BSA and Azide at 200ug/ml
100ug
$519.00
6368-MSM6-P1ABX
Purified Ab WITHOUT BSA and Azide at 1.0mg/ml
100ug
$519.00
Flat Rate Domestic: $75 | Orders outside the US - Contact Us for Order Information | Ships next business day

Applications & Dilutions

Applications Tested Dillution Protocol Note
Immunohistochemistry (IHC)
1-2ug/ml
30 min at RT. Staining of formalin-fixed tissues requires heating tissue sections in 10mM Tris with 1mM EDTA, pH 9.0, for 45 min at 95°C followed by cooling at RT for 20 minutes

Summary

Small inducible cytokine A23 precursor (CCL23), or CK-b-8, is a chemokine that binds to the receptor CCR1. It is involved in the immune response and inhibits production of polymorphonuclear leukocytes (PMNs) and monocytes in bone marrow. In addition, CCL23 has a splice variant, CK-b-8-1, and both variants chemoattract lymphocytes, monoctyes and neutrophils. CCL23 also promotes angiogenesis and endothelial cell migration via its actions on the CCR1 receptor. Proinflammatory proteases cleave an N-terminal domain of CCL23, improving the potency of its CCR1-mediated signaling up to 1000- fold in vitro. N-truncated CCL23 is found in high levels in synovial fluids of rheumatoid arthritis patients, suggesting a role of protease release during an inflammatory response. High levels of CCL23 mRNA expression occur in human fetal bone osteoblasts and chondrocytes, indicating a possible role for CCL23 in the recruitment of osteoclast precursors to the sites of bone reabsorption.

Product Properties & Targets

Antibody Type
Host
Mouse
Applications
Species Reactivity
Isotype / Light Chain
IgG2c / Kappa
Cellular Localization
Secreted.
Gene Name
Positive Control
High levels in adult lung|liver|skeletal muscle and pancreas.
Immunogen
Recombinant fragment (around aa1-120) of human CCL23 protein (exact sequence is proprietary)
Alternate Names
C-C motif chemokine 23 | CCL23(19-99) | CCL23(22-99) | CCL23(27-99) | CCL23(30-99), CK-beta-8, Macrophage inflammatory protein 3, Myeloid progenitor inhibitory factor 1, Small-inducible cytokine A23, C C motif chemokine ligand 23; C6 beta chemokine; CK-beta-8; CKB 8; Ckb-8-1; CKB8; Hmrp-2a; Macrophage inflammatory protein 3; MIP3; MPIF1; Myeloid progenitor inhibitory factor 1; OTTHUMP00000163948; SCYA 23; SCYA23; Small inducible cytokine subfamily A (Cys-Cys), member 23; Small inducible cytokine subfamily A, member 23

Database Links

Entrez Gene ID
SwissProt

Additional Information

Clone
CCL23/4036
Chromosome Location
17q12
Mol. Weight of Antigen
13kDa

Functions

  • Shows chemotactic activity for monocytes, resting T-lymphocytes, and neutrophils, but not for activated lymphocytes. Inhibits proliferation of myeloid progenitor cells in colony formation assays. This protein can bind heparin. Binds CCR1. CCL23(19-99), CCL23(22-99), CCL23(27-99), CCL23(30-99) are more potent chemoattractants than CCL23.

Key References

  • Votta, B.J., et al. 2000. CKb-8 [CCL23], a novel CC chemokine, is chemotactic for human osteoclast precursors and is expressed in bone tissues. J. Cell. Physiol. 183: 196-207.

Storage & Stability

Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C.Antibody is stable for 24 months. Non-hazardous. No MSDS required.

Limitations

This antibody is available for research use only and is not approved for use in diagnosis.

Supplied as

200ug/ml of Ab purified from Bioreactor Concentrate by Protein A/G. Prepared in 10mM PBS with 0.05% BSA & 0.05% azide. Also available WITHOUT BSA & azide at 1.0mg/ml.

Warranty

There are no warranties, expressed or implied, which extend beyond this description. Company is not liable for any personal injury or economic loss resulting from this product.

Reviews

There are no reviews yet.

Be the first to review “CCL23 / Myeloid Progenitor Inhibitory Factor 1 Antibody”

Your email address will not be published. Required fields are marked *

PARTNERSHIP OPPORTUNITIES

NeoBiotechnologies holds Exclusive rights to 10,000 recombinant and hybridoma antibody products, available for Licensing or Collaboration.

LETS TALK